>
Intervacc AB logo

IVACC - Intervacc AB Share Price

SEK83.6 -1.0  -1.2%

Last Trade - 5:00pm

Sector
Healthcare
Size
Mid Cap
Market Cap £362.6m
Enterprise Value £348.6m
Revenue £408k
Position in Universe 560th / 1829
Bullish
Bearish
Unlock IVACC Revenue
Momentum
Relative Strength (%)
1m +6.80%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -6.21%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
62.8 55.6 48.0 35.6 12.1 4.78 35.0 116 -40.3%
-98.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Intervacc AB revenues decreased 61% to SEK4.8M. Net lossdecreased 8% to SEK25.6M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Lower net loss reflectsEmployee benefit expenses decrease of 8% to SEK15.2M(expense), Other operating expenses decrease of 48% toSEK207K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for IVACC
Graphical History

Revenue

IVACC Revenue Unlock IVACC Revenue

Net Income

IVACC Net Income Unlock IVACC Revenue

Normalised EPS

IVACC Normalised EPS Unlock IVACC Revenue

PE Ratio Range

IVACC PE Ratio Range Unlock IVACC Revenue

Dividend Yield Range

IVACC Dividend Yield Range Unlock IVACC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
IVACC EPS Forecasts Unlock IVACC Revenue
Profile Summary

Intervacc AB is a Sweden-based biotechnology company. It develops vaccines based on recombinant proteins for animal health care. The Company’s candidate vaccine against strangles Strangvac consists of soluble recombinant proteins and devoids any living infectious agent. The Company operates through two subsidiaries: Nord Vacc Lakemedel AB and Mybac-Vettech AB. Nord Vacc Lakemedel AB markets and distributes veterinary vaccines, pharmaceuticals and vitamins on European market. It offers assortment of fur animal vaccines, the Febrivac range, as well as swine vaccines for Swedish and Danish markets. Mybac-Vettech AB is a technology platform that focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since April 7, 2017
No. of Shareholders: 9,730
No. of Employees: 12
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 50,160,388
Free Float (0.0%)
Eligible for
ISAs
SIPPs
IVACC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IVACC
Upcoming Events for IVACC
Frequently Asked Questions for Intervacc AB
What is the Intervacc AB share price?

As of 5:00pm, shares in Intervacc AB are trading at SEK83.6, giving the company a market capitalisation of £362.6m. This share price information is delayed by 15 minutes.

How has the Intervacc AB share price performed this year?

Shares in Intervacc AB are currently trading at SEK83.6 and the price has moved by 0.297k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Intervacc AB price has moved by 0.208k% over the past year.

What are the analyst and broker recommendations for Intervacc AB?

Of the analysts with advisory recommendations for Intervacc AB, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Intervacc AB is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Intervacc AB next release its financial results?

Intervacc AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Intervacc AB dividend yield?

Intervacc AB does not currently pay a dividend.

Does Intervacc AB pay a dividend?

Intervacc AB does not currently pay a dividend.

When does Intervacc AB next pay dividends?

Intervacc AB does not currently pay a dividend.

How do I buy Intervacc AB shares?

To buy shares in Intervacc AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Intervacc AB?

Shares in Intervacc AB are currently trading at SEK83.6, giving the company a market capitalisation of £362.6m.

Where are Intervacc AB shares listed? Where are Intervacc AB shares listed?

Here are the trading details for Intervacc AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: IVACC
What kind of share is Intervacc AB?

Based on an overall assessment of its quality, value and momentum, Intervacc AB is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Intervacc AB share price forecast 2021?

Shares in Intervacc AB are currently priced at SEK83.6. At that level they are trading at 30.02% discount to the analyst consensus target price of 0.00.

Analysts covering Intervacc AB currently have a consensus Earnings Per Share (EPS) forecast of -0.48 for the next financial year.

How can I tell whether the Intervacc AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Intervacc AB. Over the past six months, the relative strength of its shares against the market has been 39.98%. At the current price of SEK83.6, shares in Intervacc AB are trading at 66.65% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Intervacc AB PE Ratio?

We were not able to find PE ratio data for Intervacc AB.

Who are the key directors of Intervacc AB?

Intervacc AB's management team is headed by:

Rune Bergman - VBD
Jan-Ingmar Flock - CSO
Bengt Guss - IND
Olof Zachrisson - OTH
Andreas Johansson - VPR
Bjorn Sjostrand - CHM
Newton Aguiar - DRC
Marianne Hansson - DRC
Torben Joergensen - DRC
Bert Urlings - DRC
Andreas Andersson - CEO
Jan Persson - CFO
Who are the major shareholders of Intervacc AB?

Here are the top five shareholders of Intervacc AB based on the size of their shareholding:

Swedbank Robur Fonder AB Investment Advisor/Hedge Fund
Percentage owned: 6.82% (3.42m shares)
Swedbank Robur Smabolagsfond Europa Mutual Fund
Percentage owned: 6.82% (3.42m shares)
Eklund (T) Individual Investor
Percentage owned: 5.69% (2.85m shares)
Aguiar (N) Individual Investor
Percentage owned: 5.69% (2.85m shares)
Fjärde AP-Fonden Pension Fund
Percentage owned: 4.68% (2.35m shares)
Similar to IVACC
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.